inactivated brands

EACH DOSE (05 ML) IS FORMULATED TO CONTAIN TETANUS TOXOID 5 LF DIPHTHERIA TOXOID 2 LF ACELLULAR PERTUSSIS( PERTUSSIS TOXOID (PT) 25 G AND FILAMENTOUS HAEMAGGLUTININ (FHA) 5 G PERTACTIN (PRN) 3 G FIMBRIAE TYPES 2 AND 3 (FIM) 5 G ) INACTIV

INACTIVATED HEPATITIS A VIRUS (GBM STRAIN) ___160 ANTIGEN UNITS PER 05 ML DOSE

INACTIVATED HEPATITIS A VIRUS (GBM STRAIN) __80 ANTIGEN UNITS PER 05 ML DOSE

EACH DOSE (0.5 ML) OF VACCINE CONTAINSINACTIVATED NEWCASTLE DISEASE VIRUS, STRAIN NDV-SZ LASOTA INDUCING MIN. 6 LOG2 HI TITRE WITH 1 DOSE OR INDUCING MIN. 4 LOG2 HI TITRE WITH 1/50 DOSE OR MIN. 50 PD50 INACTIVATED AVIAN INFECTIOUS BRONCHITIS VIRUS,STRAI

INACTIVATED NEWCASTLE DISEASE VIRUS STRAIN NDV-SZ LASOTA …….. INDUCING MIN. 4 LOG2 HI OR MIN. 50 PD50

INACTIVATED NEWCASTLE DISEASE VIRUS STRAIN NDV-SZ LASOTA ………………… INDUCING MIN. 5 LOG2 HI TITER OR MIN. 50 PD50 IN CHALLENGE

2.5 IU

0.5ML/BIRD

6.0 µG IN 0.5 ML

(1) 0.5ML/SYRINGE (EACH PRE-FILLED SYRINGE CONTAINS 0.5ML OF PRODUCT FOR EACH ADMINISTRATION, EACH DOSE CONTAINS 6.5 U OF INACTIVATED SARSCOV-2 ANTIGEN). (2) 0.5ML/VIAL (EACH VIAL CONTAINS 0.5ML OF PRODUCT FOR EACH ADMINISTRATION, EACH DOSE CONTAINS 6.5 U OF INACTIVATED SARS-COV-2 ANTIGEN).

A SINGLE HUMAN DOSE (0.5 ML) OF SABIN INACTIVATED POLIO VACCINE CONTAINS: 5 D-ANTIGEN UNITS, 8 D-ANTIGEN UNITS AND 16 D-ANTIGEN UNITS OF INACTIVATED POLIOVIRUS TYPES 1, 2 AND 3(SABIN STRAIN), RESPECTIVELY AS ACTIVE INGREDIENTS.

1,500 L.E.U/1.5ML

6.5 UNIT / 0.5 ML

500U/DOSE FOR ADULT USE

LIVE CANINE PARVOVIRUS (CPV) STRAIN C-780916 10TCID50 LIVECANINE DISTEMPER VIRUS (CDV) LEDERLE STRAIN 10TCID50 LIVE CANINE ADENOVIRUS TYPE 2 (CAV 2) MANHATTAN STRAIN 10DICT50 LIQUID PORTION: INACTIVATED LEPTOSPIA ICTEROHAEMORRHAGIAE & LEPTOSPIR

INACTIVATED POLIOMYELITIS VIRUS TYPE 1 -40 D-ANTIGEN UNITS INACTIVATED POLIOMYELITIS VIRUS TYPE 2- 8 D-ANTIGEN UNITS INACTIVATED POLIOMYELITIS VIRUS TYPE 3 -32 D-ANTIGEN UNITS

INACTIVATED RABIES VACCINE

2.5 I.U.

ONE DOSE (0.5ML)

0.5ML/VIAL. EACH SINGLE DOSE IS 0.5ML, CONTAINING 15 MICROGRAMS OF HEMAGGLUTININ OF EACH OF THE INFLUENZA VIRUS STRAINS

CANINE DISTEMPER VIRUS B.P.10_ TCID CANINE CONTAGIOUS HEPATITIS VIRUS B.P.10_ TCID CANINE PARVOVIRUS B.P.10_ TCID INACTIVATED CONTAGIOUS CANINE HEPATITIS VIRUS B.P. INACTIVATED LEPTOSPIRA CANICOLA B.P.2 X 10 ORGANISMS INACTIVATED LEPTOSPIR

EACH 0.1 CONTAINS: WATER PHASE CONTAINING INACTIVATED NDV, V.H STRAIN. AT LEAST 10 POWER 8.1EID 50

TYPE 1_>700 DU/ML, TYPE 2_>500 DU/ML, TYPE 3_>700DU/ML

NOT LESS THAN 1 I.U PER ML

INACTIVATED AND CONCENTRATED NEWCASTLE DISEASE VIRUS, B1 TYPE MIN 108.8 EID50 INACTIVATED AND CONCENTRATED INFECTIOUS BRONCHITIS VIRUS MASSACHUSETTS TYPE, STRAIN M-41 MIN 106.1 EID50 INACTIVATED AND CONCENTRATED INFECTIOUS BRONCHITIS VIRUS MASSACHUSETTS T

EACH 0.5 ML DOSE OF VACCINE CONTAINS:DIPHTHERIA TOXOID 30IU,TETANUS TOXOID 60IU, BORDETELLA PERTUSSIS ANTIGENS (WHOLE CELL) 4IU, HEPATITIS B SURFACE ANTIGEN (RDNA) 10UG, PURIFIED CAPSULAR POLYSACCHARIDE OF HIB 10UG

TYPE 1 (MAHONEY):- 40DU‡, TYPE 2 (MEF1):- 8DU‡, AND TYPE 3 (SAUKETT):- 32DU‡. ‡ D- ANTIGEN UNIT.

CLSTRIDIUM PERFRINGENS ANATOXIN (TYPES BC & D) CLOSTRIDIUM SEPTICUM & CLOSTRIDIUM NOVYI ANATOXIN IN ADEQUATE LEVELS TO INDUCE 10 IU OF TYPE B CLOSTRDIUM PERFRINGENS BETA-ANTITOXIN/ML OF SERUM 10IU OF TYPE C CLOSTRIDIUM PERFRINGENS BETA-ANTITOXIN/ML OF

>720 EU & 20 MCG/ML RESPECTIVELY

>360 EU & 10 MCG / 0.5 ML RESPECTIVELY

VIRUS FEBRIS CONTAGIOSAE CANIS MIN. 103.0TCID50, MAX. 104.5TCID50 VIRUS LARYNGOTRACHEITIDIS CONTAGIOSAE CANIS MIN. 103.5TCID50, MAX. 104.5TCID50 PARVOVIRUS ENTERITIDIS CANIS MIN. 104.5TCID50, MAX. 105.5TCID50 VIRUS PARAINFLUENSIS CANIS MIN. 103.0TCID50, M

VIRUS FEBRIS CONTAGIOSAE CANIS MIN. 103.0TCID50, MAX. 104.5TCID50 VIRUS LARYNGOTRACHEITIDIS CONTAGIOSAE CANIS MIN. 103.5TCID50, MAX. 104.5TCID50 PARVOVIRUS ENTERITIDIS CANIS MIN. 104.5TCID50, MAX. 105.5TCID50 VIRUS PARAINFLUENSIS CANIS MIN. 103.0TCID50, M

VIRUS RABIEI INACTIVATED, SAD VNUKOVO-32 STRAIN MIN 2 IU

POTENCY-2.5 I.U